The present invention generally relates to novel arylpiperazines. In particular, these arylpiperazines can be used as neuroprotective agents. The invention also relates to a process for the manufacture of the novel compounds. Further, the invention relates to the use of the novel arylpiperazines in the treatment of diseases associated with, accompanied by or caused by mitochondrial stress.
本发明一般涉及新型芳基
哌嗪。具体而言,这些芳基
哌嗪可用作神经保护剂。本发明还涉及一种制造这些新型化合物的方法。此外,本发明还涉及将这些新型芳基
哌嗪用于治疗与、伴随或由线粒体应激引起的疾病的用途。